Marek Radkowski - Infectious Diseases

Author Information

Marek Radkowski is affiliated with the Department of Immunopathology of Infectious Diseases at the Medical University of Warsaw, located in Warsaw, Poland. His work primarily focuses on the field of infectious diseases, contributing significantly to the understanding of various viral infections and their interactions with the human immune system. With a robust academic background and a profound commitment to research, Marek Radkowski has established himself as a leading expert in his field.

Research Contributions

Marek Radkowski has made extensive contributions to the field of infectious diseases, particularly in understanding the immune response to viral infections. His recent research includes exploring T-cell exhaustion in chronic hepatitis C virus infection, the role of gut microbiota in gastrointestinal cancers, and the effectiveness of COVID-19 vaccine booster doses among healthcare workers. Additionally, he has investigated the presence of viral agents in cerebrospinal fluid in patients with multiple sclerosis and autoimmune encephalitis. His work often involves utilizing advanced techniques such as next-generation sequencing and metagenomics to enhance the diagnosis and understanding of viral infections.

Aliases

Marek Radkowski is also known by several aliases, which include M M Radkowski, M Radkowski, and M. Radkowski. These variations are used across different publications and databases, reflecting the common practice of authors being listed under different name formats in scientific literature.

Publication and Citation Metrics

Metric	Value
Citation Count	4889
h-index	39
Paper Count	228

Publications:

CD8+ T-Cell Exhaustion Phenotype in Chronic Hepatitis C Virus Infection Is Associated With Epitope Sequence Variation

DOI: 10.3389/fimmu.2022.832206

Year: 2022

The Role of Gut Microbiota in Gastrointestinal Tract Cancers

DOI: 10.1007/s00005-021-00641-6

Year: 2022

The Beneficial Effect of the COVID-19 Vaccine Booster Dose among Healthcare Workers in an Infectious Diseases Center

DOI: 10.3390/vaccines10040552

Year: 2022

Seronegative Infection with Toxoplasma gondii in Asymptomatic Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Patients and in Blood Donors

DOI: 10.3390/jcm11030638

Year: 2022

Genetically determined hypertensive phenotype affects gut microbiota composition, but not vice versa

DOI: 10.1097/HJH.0000000000002864

Year: 2021

Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics

DOI: 10.1371/journal.pone.0240601

Year: 2020

Next-generation sequencing in the diagnosis of viral encephalitis: sensitivity and clinical limitations

DOI: 10.1038/s41598-020-73156-3

Year: 2020

Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C

DOI: 10.1038/s41598-020-73137-6

Year: 2020

Differences and similarities in clinical manifestations of Listeria monocytogenes and Mycobacterium tuberculous meningitis.

DOI: 10.32394/pe.74.25

Year: 2020

Search for Viral Infections in Cerebrospinal Fluid From Patients With Autoimmune Encephalitis

DOI: 10.1093/ofid/ofaa468

Year: 2020

How Does Climate Change Influence Infectious Diseases?

What Are Some Key Infectious Disease Research Initiatives by the NIH?

How are Zoonoses Transmitted?

What Could Be Causing Weight Loss?

How Do Serological Tests Work?

How Can Dengue Be Prevented?

What Are Emerging Bacterial Threats?

How should you prepare for medical emergencies abroad?

Are condoms effective against all STIs?

What Factors Influence Airborne Transmission?

Partnered Content Networks

Relevant Topics